Behavioural effects of high fat diet in adult Nrg1 type III transgenic mice.


Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
13 01 2020
Historique:
received: 21 06 2019
revised: 22 08 2019
accepted: 05 09 2019
pubmed: 10 9 2019
medline: 24 4 2021
entrez: 10 9 2019
Statut: ppublish

Résumé

Some diets appear to have detrimental effects on schizophrenia symptoms. Neuregulin 1 (NRG1) is a risk gene for schizophrenia and a recently developed transgenic mouse model for Nrg1 type III demonstrates a schizophrenia-relevant phenotype. The current study evaluated the behavioural response of Nrg1 type III transgenic mice to a high fat diet (HFD) to determine the potential interactive impact of diets and genetic risk factors on disease symptoms. Male and female Nrg1 III and control littermates (N = 13-24) were exposed during adulthood to either HFD or standard chow diet (CHOW) for eight weeks before being tested in behavioural domains relevant to schizophrenia. Locomotion and exploration, anxiety, social behaviours (including social preference), sensorimotor gating (i.e. prepulse inhibition, PPI), associative learning, and anhedonia were assessed. HFD increased the body weight gain of mice, suppressed locomotion, exploration, and anxiety-related behaviours in a sex-dependent manner. HFD augmented the PPI response in male mice and decreased anhedonia in a sucrose preference test. Finally, HFD had a sex-dependent impact on fear-associated memory with HFD-induced cognitive impairments being most prominent in Nrg1 transgenic females. In conclusion, HFD and mutant Nrg1 III interactively impair particular cognitive domains in a sex-specific manner. Thus, our preclinical data suggest that genetic predisposition to the schizophrenia risk gene NRG1 may modulate detrimental behavioural effects of diets. This indicates the importance to research further the role of particular diets in the context of populations at risk to develop schizophrenia.

Identifiants

pubmed: 31499092
pii: S0166-4328(19)30972-6
doi: 10.1016/j.bbr.2019.112217
pii:
doi:

Substances chimiques

NRG1 protein, human 0
Neuregulin-1 0
Protein Isoforms 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112217

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Jerzy Zieba (J)

Neuroscience Research Australia, Randwick, NSW, 2031, Australia; School of Medical Sciences, UNSW Sydney, NSW, 2052, Australia.

Margaret J Morris (MJ)

School of Medical Sciences, UNSW Sydney, NSW, 2052, Australia.

Cynthia Shannon Weickert (CS)

Neuroscience Research Australia, Randwick, NSW, 2031, Australia; Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, NSW, 2031, Australia; Department of Neuroscience & Physiology, Upstate Medical University, Syracuse, New York, 13210, USA; School of Psychiatry, Faculty of Medicine, UNSW Sydney, NSW, 2052, Australia.

Tim Karl (T)

Neuroscience Research Australia, Randwick, NSW, 2031, Australia; School of Medical Sciences, UNSW Sydney, NSW, 2052, Australia; School of Medicine, Western Sydney University, NSW, 2560, Australia. Electronic address: t.karl@westernsydney.edu.au.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH